BION-1301

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BION-1301, covering 2020-09-07 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) [Phase 1, Phase 2]

See pricing